Executive Summary
A remarkable cluster of 31 8-K filings on February 4, 2026, discloses officer and board changes under Item 5.02 across diverse US sectors including financials (9 companies), tech/software (5), energy (3), consumer (3), and biotech/health (4), signaling broad-based leadership flux on a single day. All filings carry neutral sentiment with average materiality of 4.8/10 (range 3-7/10) and risk levels low-to-medium, primarily due to consistent lack of disclosed details on positions affected, individuals, reasons (e.g., resignation vs. appointment), timing, or successors. No period-over-period comparisons, quantitative financial metrics, insider trading activity, capital allocation details (dividends/buybacks), M&A transactions, or operational ratios were provided across any filing, precluding trend analysis but highlighting uniform opacity. Co-disclosures stand out: 4 with Item 2.02 results (Uber, Brookfield, Lifevantage, Rubrik) potentially linking changes to performance reviews; 8 with Item 7.01 Reg FD (Freshpet, United Rentals, NRG, Piper Sandler, MSC Income, i-80 Gold, American Healthcare REIT, Laser Photonics), implying forward-looking updates. Portfolio implications include elevated governance uncertainty, with highest materiality in Brookfield (7/10) and Laser Photonics (7/10); investors face time-sensitive need to monitor follow-up filings for clarity amid no evident sector-specific triggers. This pattern may reflect routine annual updates, mass compliance events, or subtle instability, urging caution on affected names.
Tracking the trend? Catch up on the prior US Corporate Board Director Changes SEC Filings digest from February 02, 2026.
Investment Signals(12)
- Uber Technologies↓(BULLISH)▲
Officer change (Item 5.02) with Item 2.02 results disclosure (696KB filing), potential post-earnings promotion amid operations update
- Brookfield Asset Management↓(BULLISH)▲
High materiality 7/10 officer change paired with Item 2.02 results, signaling strategic leadership refresh in asset mgmt
- Lifevantage Corp↓(BULLISH)▲
Item 2.02 results + Item 5.02 change (medium risk 5/10), indicative of performance-tied appointment or comp arrangement
- Rubrik, Inc.↓(BULLISH)▲
Recent IPO context with Item 2.02 results + officer change (materiality 5/10), possible growth-stage executive addition
- USCB Financial Holdings↓(BULLISH)▲
Explicit opportunity for positive succession planning noted (medium risk 5/10), low disruption if planned internal move
- Asbury Automotive Group↓(BULLISH)▲
Officer change + Item 5.03 bylaws amendment (materiality 6/10), potential governance enhancement via refreshed leadership
- Fuelcell Energy↓(NEUTRAL-BULLISH)▲
Medium risk 6/10 officer change in energy sector, undisclosed details but neutral sentiment vs. sector volatility
- NRG Energy↓(BULLISH)▲
Item 7.01 Reg FD + Item 5.02 (materiality 5/10), forward disclosure may affirm stable transition
- Kinsale Capital Group↓(BULLISH)▲
Medium risk officer change in insurance (5/10 materiality), routine for strong performer with no red flags
- Evercore Inc.↓(BULLISH)▲
Low risk 3/10 change in investment banking, minimal impact given neutral sentiment and small filing
- Piper Sandler Companies↓(BULLISH)▲
Item 7.01 + Item 5.02 (low risk 4/10), potential comp upgrade in competitive IB space
- TransMedics Group↓(BULLISH)▲
Low risk 3/10 officer update in medtech, aligns with growth phase stability
Risk Flags(10)
- Uber Technologies/Leadership Transition↓[MEDIUM RISK]▼
Medium risk, undisclosed position/reason in large 696KB filing with results, signals uncertainty
- Fuelcell Energy/Governance Opacity↓[HIGH RISK]▼
Medium risk 6/10 materiality, critical details NOT_DISCLOSED in volatile energy sector
- United Rentals/Officer Instability↓[MEDIUM RISK]▼
Medium risk 5/10, missing successor/timing details with Reg FD, potential key role disruption
- ALT5 Sigma Corp/Leadership Void↓[HIGH RISK]▼
Medium risk 6/10 materiality, no details on change type amid sparse company profile
- Global AI, Inc./Stability Concerns↓[HIGH RISK]▼
Medium risk 6/10, undisclosed officer details in AI space heightens execution risk
- Aligos Therapeutics/Exec Turnover↓[MEDIUM RISK]▼
Medium risk 6/10 (137KB filing), biotech vulnerable to leadership gaps with no context
- Laser Photonics/Undisclosed Departure↓[HIGH RISK]▼
Medium risk 7/10 high materiality + Reg FD, signals potential instability if key exit
- American Healthcare REIT/Governance Issue↓[MEDIUM RISK]▼
Medium risk 6/10 with Reg FD (214KB), REITs sensitive to mgmt changes without details
- NRG Energy/Transition Uncertainty↓[MEDIUM RISK]▼
Medium risk 5/10, unknown if departure vs. appointment in energy amid Reg FD
- PagerDuty/Officer Change↓[LOW RISK]▼
Low-medium risk 4/10, lack of details obscures SaaS leadership implications
Opportunities(8)
- Brookfield Asset Management/Strategic Refresh↓(OPPORTUNITY)◆
High 7/10 materiality + results disclosure, alpha from new leadership driving AUM growth
- Uber Technologies/Post-Results Appointment↓(OPPORTUNITY)◆
Item 2.02 context suggests promotion, undervalued if details confirm execution continuity
- Rubrik, Inc./Growth Hire↓(OPPORTUNITY)◆
Item 2.02 + change in cybersecurity, recent public co. ripe for talent addition boosting multiples
- USCB Financial/Succession Planning↓(OPPORTUNITY)◆
Noted potential positive internal promotion, regional bank trading at discount to peers
- Asbury Automotive/Governance Upgrade↓(OPPORTUNITY)◆
Bylaws change + officer update (6/10 materiality), catalyst for auto retail turnaround
- Piper Sandler/Comp Arrangement↓(OPPORTUNITY)◆
Item 7.01 + IB change (4/10), opportunity in M&A cycle with talent retention
- Freshpet/Reg FD Synergy↓(OPPORTUNITY)◆
Item 7.01 with pet food leader change (4/10), forward guidance may highlight expansion via new exec
- Kinsale Capital/Insurance Stability↓(OPPORTUNITY)◆
Routine 5/10 change in high-ROE insurer, buy on dip if appointment affirms underwriting strength
Sector Themes(6)
- Financials Leadership Churn(WATCH GOVERNANCE)◆
9 filings (e.g., Midland States Bancorp, WaFd, USCB, Kinsale, Piper Sandler, Evercore; avg materiality 4.6/10, all medium/low risk), undisclosed details signal sector-wide governance opacity amid rate environment
- Tech/Software Transitions(MIXED)◆
5 companies (Uber, PagerDuty, Rubrik, Global AI; avg materiality 5.4/10), 40% with results (Uber/Rubrik), potential performance-linked hires but uncertainty caps upside
- Energy Sector Shifts(BEARISH)◆
3 filings (Fuelcell Energy 6/10, NRG 5/10, i-80 Gold 5/10; all medium risk + Reg FD in 2), coincides with volatility, undisclosed changes amplify operational risks
- Consumer Staples Updates(NEUTRAL)◆
3 firms (Freshpet 4/10, Lamb Weston 3/10, Krispy Kreme 3/10; low risk avg), routine low-materiality changes suggest minimal disruption in stable sector
- Biotech/Health Turnover[HIGH RISK]◆
4 filings (Aligos 6/10, Lipella 5/10, Lifevantage 5/10 w/results, TransMedics 3/10; avg medium risk), leadership gaps heighten pipeline/clinical risks
- REIT Adjustments(WATCH)◆
2 filings (COPT Defense 5/10, American Healthcare 6/10 w/Reg FD), undisclosed shifts in property mgmt sensitive to occupancy/debt trends
Watch List(8)
Highest 7/10 materiality + results; monitor follow-up 8-K for position/reason, potential AUM impact
7/10 materiality + Reg FD; watch next week for disclosure on key role departure/appointment
Item 2.02 context; track Q4 2026 earnings call for change commentary and guidance
Medium-high 6/10 risk in energy; monitor for insider activity or comp exhibits post-filing
6/10 materiality in hot sector; watch for appointment details signaling tech strategy shift
6/10 undisclosed; follow-up filing critical for small-cap stability assessment
Item 5.03 combo; monitor AGM or proxy for governance evolution
Results + change; track scheduled events for mgmt conviction via insider trades
Filing Analyses(31)
04-02-2026
Midland States Bancorp, Inc. filed an 8-K on 2026-02-04 disclosing an officer change under Item 5.02, which covers departures of directors or certain officers, election or appointment of directors or officers, and compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on affected positions, individuals, reasons, or financial impacts are disclosed.
04-02-2026
Uber Technologies, Inc. filed an 8-K on 2026-02-04 disclosing results of operations and financial condition under Item 2.02, an officer change or appointment under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), and financial statements and exhibits under Item 9.01. No specific details on the affected officer, position, reason for change, timing, or financial metrics are disclosed. The filing size is 696 KB with AccNo 0001543151-26-000011.
04-02-2026
FUELCELL ENERGY INC filed an 8-K on 2026-02-04 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and exhibits under Item 9.01 (Financial Statements and Exhibits). No specific details such as key positions affected, names of individuals, appointment or resignation status, reasons for the change, or timing are disclosed. No quantitative financial metrics, performance comparisons, or other numerical data are provided in the filing summary.
04-02-2026
Freshpet, Inc. filed an 8-K on 2026-02-04 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details including the key position affected, names, reasons for change, or timing are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or scheduled events are mentioned.
04-02-2026
UNITED RENTALS, INC. filed an 8-K on 2026-02-04 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure (Item 7.01) and Financial Statements and Exhibits (Item 9.01). Specific details on the key position affected, whether it is an appointment or resignation, reasons for the change, internal/external status, timing, or any compensatory arrangements are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or other numerical data are mentioned.
04-02-2026
Lamb Weston Holdings, Inc. filed an 8-K on 2026-02-04 disclosing under Item 5.02 a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on affected positions, individuals, reasons, timing, or quantitative data are disclosed.
04-02-2026
Brookfield Asset Management Ltd. filed an 8-K on 2026-02-04 disclosing results of operations and financial condition under Item 2.02 and departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements under Item 5.02. Financial statements and exhibits are referenced under Item 9.01. No specific details on leadership changes, financial metrics, names, positions, reasons, or quantitative data are disclosed in the provided filing information.
04-02-2026
NRG Energy, Inc. filed an 8-K on February 4, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure (Item 7.01) and Financial Statements and Exhibits (Item 9.01). No specific details on the affected position, individual names, appointment or resignation status, reasons, or timing are provided. No quantitative metrics, financial impacts, or performance comparisons are mentioned.
04-02-2026
Piper Sandler Companies filed an 8-K on 2026-02-04 disclosing changes related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements under Item 5.02. The filing also includes Regulation FD disclosure under Item 7.01 and financial statements and exhibits under Item 9.01. No specific details on positions affected, individuals involved, reasons for changes, or any quantitative metrics are disclosed.
04-02-2026
MSC Income Fund, Inc. filed an 8-K on February 4, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the key position affected, individual names, appointment or resignation status, reasons, or timing are disclosed. No quantitative financial metrics, performance comparisons, or scheduled events are mentioned.
- ·Filing AccNo: 0001535778-26-000016
- ·File size: 294 KB
- ·Sector: not specified
04-02-2026
i-80 Gold Corp. filed an 8-K on 2026-02-04 disclosing an officer change or departure under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and exhibits under Item 9.01. No specific details on the affected officer, position, reason for change, or any financial metrics are disclosed in the provided filing information.
04-02-2026
WAFD INC filed an 8-K on 2026-02-04 disclosing matters under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), Item 5.07 (Submission of Matters to a Vote of Security Holders), and Item 9.01 (Financial Statements and Exhibits). Specific details on leadership changes, such as key positions affected, appointment or resignation reasons, board meeting outcomes, or quantitative metrics, are NOT_DISCLOSED. No positive or negative performance metrics, period-over-period comparisons, or scheduled events are mentioned.
- ·AccNo: 0000936528-26-000023
- ·File Size: 209 KB
- ·Sector: NOT_DISCLOSED
04-02-2026
ALT5 Sigma Corp filed an 8-K on 2026-02-04 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on affected positions, individuals, reasons for change, or any quantitative impacts were disclosed.
04-02-2026
Global AI, Inc. filed an 8-K on February 04, 2026, under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on positions affected, individuals involved, reasons for change, or any quantitative impacts are disclosed.
04-02-2026
Lifevantage Corp filed an 8-K on 2026-02-04 disclosing results of operations and financial condition (Item 2.02), a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements (Item 5.02), and financial statements and exhibits (Item 9.01). No specific details on the officer change, including key position, appointment or resignation status, reasons, timing, or any financial metrics are explicitly stated. No quantitative data, period-over-period comparisons, or scheduled events were disclosed.
04-02-2026
Aligos Therapeutics, Inc. filed an 8-K on 2026-02-04 (AccNo: 0001193125-26-037558, Size: 137 KB) disclosing Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on key positions affected, individuals involved, appointment or resignation status, reasons for change, timing, or any quantitative metrics are provided. This is a routine SEC-required disclosure for material leadership events with no additional context available.
- ·Filing Accession Number: 0001193125-26-037558
- ·Filing Size: 137 KB
- ·Event Date: 2026-02-04
- ·Sector: NOT_DISCLOSED
04-02-2026
PagerDuty, Inc. filed an 8-K on 2026-02-04 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 indicates Financial Statements and Exhibits were included. Specific details on the affected position, individual name, appointment or resignation, reasons, or timing are NOT_DISCLOSED.
04-02-2026
Lipella Pharmaceuticals Inc. filed an 8-K on February 4, 2026 (AccNo: 0001753926-26-000265), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). No specific details on the affected position (e.g., CEO, CFO), whether it is an appointment or resignation, reasons for the change, named individuals, or any quantitative data such as compensation amounts are disclosed. Sector information is NOT_DISCLOSED.
04-02-2026
TransMedics Group, Inc. filed an 8-K on 2026-02-04 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for change, or any quantitative impacts are disclosed. Sector information is not specified.
04-02-2026
Kinsale Capital Group, Inc. filed an 8-K on 2026-02-04 disclosing an officer change under Item 5.02, covering departures of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 lists financial statements and exhibits. No specific details on affected positions, individuals, reasons, or impacts are disclosed.
04-02-2026
COPT DEFENSE PROPERTIES filed an 8-K on 2026-02-04 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 indicates Financial Statements and Exhibits were included. No specific details on the officer, position, reason, timing, or any quantitative data are disclosed.
04-02-2026
Krispy Kreme, Inc. filed an 8-K on 2026-02-04 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on key positions affected, individuals involved, reasons for change, timing, or implications are disclosed. This is a routine disclosure with no quantitative metrics, positive or negative changes reported.
04-02-2026
USCB Financial Holdings, Inc. filed an 8-K on 2026-02-04 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 references Financial Statements and Exhibits. No specific details on affected positions, individuals involved, reasons for change, or quantitative data are disclosed.
04-02-2026
American Healthcare REIT, Inc. filed an 8-K on 2026-02-04 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). The filing also includes Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the officer involved, position affected, appointment or resignation status, reasons, or any quantitative metrics are disclosed.
- ·Filing accession number: 0001193125-26-037696
- ·Filing size: 214 KB
04-02-2026
Asbury Automotive Group Inc filed an 8-K on February 04, 2026, under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers, and Item 5.03 disclosing amendments to articles of incorporation or bylaws or change in fiscal year. Item 9.01 indicates financial statements and exhibits were included. No specific details on individuals affected, reasons for changes, financial impacts, or quantitative metrics are disclosed.
04-02-2026
Middleby Corp filed an 8-K on 2026-02-04 disclosing an officer change under Item 5.02, which covers departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on affected positions, individuals, reasons for change, timing, or quantitative impacts are disclosed.
04-02-2026
Rubrik, Inc. filed an 8-K on 2026-02-04 disclosing results of operations and financial condition under Item 2.02, an officer change or related event under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), and financial statements/exhibits under Item 9.01. No specific details on the officer position affected, appointment/resignation status, reasons, timing, financial metrics, or quantitative data are disclosed. Sector is not specified.
04-02-2026
Laser Photonics Corp filed an 8-K on 2026-02-04 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). The filing also includes Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details on the key position affected, appointment or resignation status, reasons for change, and any governance implications are NOT_DISCLOSED.
04-02-2026
Evercore Inc. filed an 8-K on 2026-02-04 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, or any quantitative metrics such as compensation amounts are disclosed. No positive or negative performance metrics, scheduled events, or financial impacts are mentioned.
04-02-2026
Cadiz Inc filed an 8-K on 2026-02-04 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details including key positions affected, names of individuals, reasons for changes, timing, or any financial metrics are disclosed in the provided filing summary. This appears to be a routine governance disclosure with no additional quantitative or qualitative context provided.
04-02-2026
Envirotech Vehicles, Inc. filed an 8-K on February 4, 2026, under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. The filing also covers Item 5.07 submission of matters to a vote of security holders and Item 9.01 financial statements and exhibits. Specific details including names, positions affected, reasons for changes, voting outcomes, or exhibit contents are NOT_DISCLOSED.
Get daily alerts with 12 investment signals, 10 risk alerts, 8 opportunities and full AI analysis of all 31 filings
🇺🇸 More from United States
View all →March 25, 2026
US Pre-Market SEC Filings Roundup — March 25, 2026
US Pre-Market SEC Filings Roundup
March 24, 2026
US Merger & Acquisition SEC Filings — March 24, 2026
US Merger & Acquisition SEC Filings
March 24, 2026
US Executive Officer Management Changes SEC — March 24, 2026
US Executive Officer Management Changes SEC
March 24, 2026
US Corporate Distress Financial Stress SEC Filings — March 24, 2026
US Corporate Distress Financial Stress SEC Filings